Naujausios naujienos ir straipsniai apie genetinius tyrimus
May 3, 2026
American Heart Association. "Micro-nano-plastics found in artery-clogging plaque in the neck." ScienceDaily. ScienceDaily, 23 April 2025. <www.sciencedaily.com/releases/2025/04/250423112651.htm>...
May 3, 2026
Researchers have discovered molecular adhesives that shield insulin-producing cells from damage associated with diabetes. These findings may lead to new therapeutic approaches for managing the condition.
May 3, 2026
University of Kent. "Scientists discover skincare compound that kills drug-resistant bacteria." ScienceDaily. ScienceDaily, 21 April 2026. <www.sciencedaily.com/releases/2026/04/260420014738.htm>...
May 3, 2026
Researchers at the University of Kent have identified a skincare compound with potent antibacterial properties, capable of killing drug-resistant bacteria. This breakthrough discovery holds promise for the development of innovative treatments for bacterial infections.
May 3, 2026
Researchers at the University of Kent have identified a skincare compound that exhibits potent antibacterial activity against drug-resistant bacteria. This discovery has significant implications for the development of novel antimicrobial agents.
May 3, 2026
Scripps Research Institute. "Enzyme engineering opens door to novel therapies for Parkinson's, cancers and other hard-to-target protein diseases." ScienceDaily. ScienceDaily, 27 March 2025. <www.sc...
May 3, 2026
Researchers at the Scripps Research Institute have made significant advancements in enzyme engineering, paving the way for novel therapies to treat complex protein-related diseases such as Parkinson's and certain cancers.
May 3, 2026
Researchers at NYU Langone Health have developed a gene-based blood test that may be able to detect early signs of melanoma recurrence. This non-invasive test has shown promise in identifying patients who are at risk of cancer returning.
May 3, 2026
Researchers have developed a gene-based blood test that may help detect early signs of melanoma recurrence. This non-invasive test has shown promise in identifying patients at risk of cancer return.
